Class Ar (n = 15) | Class As (n = 30) | Class I (n = 4) | |
---|---|---|---|
Mean Age (range), years | 61.8 | 61.3 | 49 |
Histologic type | |||
Serous | 14 | 29 | 1 |
Endometrioid | 1 | - | 2 |
Mucinous | - | - | 1 |
Mixed carcinoma | - | 1 | - |
FIGO stage | |||
I | - | - | 4 |
III | 9 | 28 | - |
IV | 6 | 2 | - |
Differentiation grade | |||
Grade 1 | - | 1 | 1 |
Grade 2 | 5 | 7 | 2 |
Grade 3 | 10 | 22 | 1 |
Operation | |||
Primary surgery | 6 | 22 | 4 |
Interval surgery after three courses of chemotherapy | 3 | 8 | - |
Diagnostic biopsy, no surgery | 6 | - | - |
Residual tumour load after surgery | |||
0 cm | 8 | 24 | 4 |
0–1 cm | - | 1 | - |
1–2 cm | - | 4 | - |
> 2 cm | 7 | 1 | - |
Time to progression after first-line chemotherapy | |||
< 6 months | 15 | - | - |
6–12 months | - | - | 1 |
> 12 months | - | 22 | 2 |
No recurrence | - | 8 | 1 |
Current status | |||
No evidence of disease | - | 8 | 1 |
Alive with evidence of disease | 1 | 8 | 1 |
Died of disease | 14 | 14 | 2 |
Median follow-up, months | 16 | 35 | 18 |